The field of pharmaceutical biotechnology is evolving rapidly. A whole new arsenal of protein pharmaceuticals is being produced by recombinant techniques for cancer, viral infections, cardiovascular and hereditary disorders, and other diseases. In addition, scientists are confronted with new technologies such as polymerase chain reactions, combinatorial chemistry and gene therapy. This introductory textbook provides extensive coverage of both the basic science and the applications of biotechnology-produced pharmaceuticals, with special emphasis on their clinical use. Pharmaceutical Biotechnology serves as a complete one-stop source for undergraduate pharmacists, and it is valuable for researchers and professionals in the pharmaceutical industry as well.
Auflage
Sprache
Verlagsort
Zielgruppe
Für höhere Schule und Studium
Editions-Typ
Maße
Höhe: 279 mm
Breite: 216 mm
Gewicht
ISBN-13
978-0-415-28500-1 (9780415285001)
Copyright in bibliographic data is held by Nielsen Book Services Limited or its licensors: all rights reserved.
Schweitzer Klassifikation
Herausgeber*in
Utrecht University, Netherlands
University of British Columbia, Vancouver, Canada
Molecular Biotechnology. Biophysical and Biochemical Analysis of Recombinant Proteins Structure and Analysis of Proteins. Production and Downstream Processing of Biotech Products. Formulation of Biotech Products, Including Biopharmaceutical Considerations. Pharmacokinetics and Pharmacodynamics of Peptide and Protein Drugs. Genomics, Proteomics and Additional Biotechnology-Related Techniques. Gene Therapy. Hematopoietic Growth Factors. Interferons and Interleukins. Insulin. Growth Hormones. Vaccines. Monoclonal Antibody-Based Pharmaceuticals. Appendix A: Trastuzumab/Herceptin. Appendix B: Abciximab/ReoPro. Appendix C: Daclizumab/Zenapax and Basiliximab/Simulect. Recombinant Thrombolytic Agents. Recombinant Coagulation Factors. Recombinant Human Deoxyribonuclease. Follicle-Stimulating Hormone. Dispensing Biotechnology Products: Handling, Professional Education and Product Information. Economic Considerations in Medical Biotechnology. Biotechnology Products in the Pipeline.
